These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21887833)
1. Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity. Richman M; Wilk S; Skirtenko N; Perelman A; Rahimipour S Chemistry; 2011 Sep; 17(40):11171-7. PubMed ID: 21887833 [TBL] [Abstract][Full Text] [Related]
2. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity. Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832 [TBL] [Abstract][Full Text] [Related]
3. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease. Matharu B; El-Agnaf O; Razvi A; Austen BM Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587 [TBL] [Abstract][Full Text] [Related]
4. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
5. Effective targeting of Aβ to macrophages by sonochemically prepared surface-modified protein microspheres. Richman M; Perelman A; Gertler A; Rahimipour S Biomacromolecules; 2013 Jan; 14(1):110-6. PubMed ID: 23163430 [TBL] [Abstract][Full Text] [Related]
6. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process. Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145 [TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
8. Low-n oligomers as therapeutic targets of Alzheimer's disease. Ono K; Yamada M J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429 [TBL] [Abstract][Full Text] [Related]
9. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062 [TBL] [Abstract][Full Text] [Related]
10. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease. Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577 [TBL] [Abstract][Full Text] [Related]
11. A strategy for designing a peptide probe for detection of β-amyloid oligomers. Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399 [TBL] [Abstract][Full Text] [Related]
12. A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β. Ma JW; Zhao L; Zhao DS; Liu Q; Liu C; Wu WH; Chen YX; Zhao YF; Li YM Chem Commun (Camb); 2012 Nov; 48(85):10565-7. PubMed ID: 23001350 [TBL] [Abstract][Full Text] [Related]
13. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity? Saraiva AM; Pereira MC; Brezesinski G Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050 [TBL] [Abstract][Full Text] [Related]
14. The effect of tachykinin neuropeptides on amyloid β aggregation. Flashner E; Raviv U; Friedler A Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807 [TBL] [Abstract][Full Text] [Related]
15. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity. Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510 [TBL] [Abstract][Full Text] [Related]
16. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339 [TBL] [Abstract][Full Text] [Related]
17. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C; Ryu J; Park CB Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909 [TBL] [Abstract][Full Text] [Related]
18. Identification of distinct physiochemical properties of toxic prefibrillar species formed by Aβ peptide variants. Göransson AL; Nilsson KP; Kågedal K; Brorsson AC Biochem Biophys Res Commun; 2012 Apr; 420(4):895-900. PubMed ID: 22475489 [TBL] [Abstract][Full Text] [Related]
19. The butter flavorant, diacetyl, exacerbates β-amyloid cytotoxicity. More SS; Vartak AP; Vince R Chem Res Toxicol; 2012 Oct; 25(10):2083-91. PubMed ID: 22731744 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro. Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]